Follow
Sophia Adamia, PhD
Sophia Adamia, PhD
Instructor in Medicine, Dana-Farber cancer Institute & HMS
Verified email at dfci.harvard.edu
Title
Cited by
Cited by
Year
Hyaluronan and hyaluronan synthases: potential therapeutic targets in cancer
S Adamia, CA Maxwell, LM Pilarski
Current Drug Targets-Cardiovascular & Hematological Disorders 5 (1), 3-14, 2005
2222005
Increased incidence of transformation and myelodysplasia/acute leukemia in patients with Waldenstrom macroglobulinemia treated with nucleoside analogs
X Leleu, J Soumerai, A Roccaro, E Hatjiharissi, ZR Hunter, R Manning, ...
Journal of Clinical Oncology 27 (2), 250-255, 2009
1942009
A combined dielectrophoresis, traveling wave dielectrophoresis and electrorotation microchip for the manipulation and characterization of human malignant cells
EG Cen, C Dalton, Y Li, S Adamia, LM Pilarski, KVIS Kaler
Journal of microbiological methods 58 (3), 387-401, 2004
1892004
Lenalidomide targets clonogenic side population in multiple myeloma: pathophysiologic and clinical implications
J Jakubikova, S Adamia, M Kost-Alimova, S Klippel, D Cervi, JF Daley, ...
Blood, The Journal of the American Society of Hematology 117 (17), 4409-4419, 2011
1802011
RHAMM expression and isoform balance predict aggressive disease and poor survival in multiple myeloma
CA Maxwell, E Rasmussen, F Zhan, JJ Keats, S Adamia, E Strachan, ...
Blood 104 (4), 1151-1158, 2004
1232004
Small volume PCR in PDMS biochips with integrated fluid control and vapour barrier
AR Prakash, S Adamia, V Sieben, P Pilarski, LM Pilarski, CJ Backhouse
Sensors and Actuators B: Chemical 113 (1), 398-409, 2006
1182006
Peanut lectin binds to a subpopulation of mitochondria-rich cells in the rainbow trout gill epithelium
GG Goss, S Adamia, F Galvez
American Journal of Physiology-Regulatory, Integrative and Comparative …, 2001
1182001
Inhibition of USP10 induces degradation of oncogenic FLT3
EL Weisberg, NJ Schauer, J Yang, I Lamberto, L Doherty, S Bhatt, ...
Nature chemical biology 13 (12), 1207-1215, 2017
1132017
A genome-wide aberrant RNA splicing in patients with acute myeloid leukemia identifies novel potential disease markers and therapeutic targets
S Adamia, B Haibe-Kains, PM Pilarski, M Bar-Natan, S Pevzner, ...
Clinical cancer research 20 (5), 1135-1145, 2014
1122014
Evidence for a role of the histone deacetylase SIRT6 in DNA damage response of multiple myeloma cells
M Cea, A Cagnetta, S Adamia, C Acharya, YT Tai, M Fulciniti, H Ohguchi, ...
Blood, The Journal of the American Society of Hematology 127 (9), 1138-1150, 2016
1042016
Activity of a selective inhibitor of nuclear export, selinexor (KPT-330), against AML-initiating cells engrafted into immunosuppressed NSG mice
J Etchin, J Montero, A Berezovskaya, BT Le, A Kentsis, AL Christie, ...
Leukemia 30 (1), 0-0, 2016
942016
Reduced mitochondrial apoptotic priming drives resistance to BH3 mimetics in acute myeloid leukemia
S Bhatt, MS Pioso, EA Olesinski, B Yilma, JA Ryan, T Mashaka, B Leutz, ...
Cancer cell 38 (6), 872-890. e6, 2020
892020
Establishment of BCWM. 1 cell line for Waldenström's macroglobulinemia with productive in vivo engraftment in SCID-hu mice
DD Santos, AW Ho, O Tournilhac, E Hatjiharissi, X Leleu, L Xu, P Tassone, ...
Experimental hematology 35 (9), 1366-1375, 2007
862007
Stromal-mediated protection of tyrosine kinase inhibitor-treated BCR-ABL-expressing leukemia cells
E Weisberg, RD Wright, DW McMillin, C Mitsiades, A Ray, R Barrett, ...
Molecular cancer therapeutics 7 (5), 1121-1129, 2008
822008
Intronic splicing of hyaluronan synthase 1 (HAS1): a biologically relevant indicator of poor outcome in multiple myeloma
S Adamia, T Reiman, M Crainie, MJ Mant, AR Belch, LM Pilarski
Blood 105 (12), 4836-4844, 2005
822005
Discovery of a small-molecule type II inhibitor of wild-type and gatekeeper mutants of BCR-ABL, PDGFRα, Kit, and Src kinases: novel type II inhibitor of gatekeeper mutants
E Weisberg, HG Choi, A Ray, R Barrett, J Zhang, T Sim, W Zhou, ...
Blood, The Journal of the American Society of Hematology 115 (21), 4206-4216, 2010
812010
The JAK-STAT pathway regulates CD38 on myeloma cells in the bone marrow microenvironment: therapeutic implications
D Ogiya, J Liu, H Ohguchi, K Kurata, MK Samur, YT Tai, S Adamia, ...
Blood, The Journal of the American Society of Hematology 136 (20), 2334-2345, 2020
722020
miR-23b/SP1/c-myc forms a feed-forward loop supporting multiple myeloma cell growth
M Fulciniti, N Amodio, RL Bandi, A Cagnetta, MK Samur, C Acharya, ...
Blood cancer journal 6 (1), e380-e380, 2016
612016
Reversible resistance induced by FLT3 inhibition: a novel resistance mechanism in mutant FLT3-expressing cells
E Weisberg, A Ray, E Nelson, S Adamia, R Barrett, M Sattler, C Zhang, ...
PloS one 6 (9), e25351, 2011
602011
NOTCH2 and FLT3 gene mis-splicings are common events in patients with acute myeloid leukemia (AML): new potential targets in AML
S Adamia, M Bar-Natan, B Haibe-Kains, PM Pilarski, C Bach, S Pevzner, ...
Blood, The Journal of the American Society of Hematology 123 (18), 2816-2825, 2014
592014
The system can't perform the operation now. Try again later.
Articles 1–20